Intravenous anti-platelet therapy—GP IIb/IIIa blockers and cangrelor: What has changed recently?

S Ranjan, GS Wander - Acute Coronary Syndromes, 2020 - taylorfrancis.com
Antiplatelet therapies are an essential tool in management as well as prevention of
cardiovascular, cerebrovascular, and peripheral artery disease. The importance of a chapter …
相关文章

Intravenous anti-platelet therapy—GP IIb/IIIa blockers and cangrelor

S RANJAN, GS WANDER - Acute Coronary Syndromes, 2020 - books.google.com
Anti-platelets are an integral part in the management of coronary artery disease (CAD)
considering the fact that pathogenesis of atherothrombotic events is strongly mediated by …